Therapeutic Reference Pricing

Therapeutic Reference Pricing is a health policy mechanism that groups pharmaceutical products by therapeutic equivalence to establish a maximum reimbursement level, distinguishing itself from broader pricing strategies by aligning cost containment with clinical interchangeability within the same therapeutic class.

27

Publications

1.1K

Citations

67

Authors

43

Institutions

Publications per year

2017–2026

3

Authors

67

  1. SS
    Sebastian Schneeweiß

    Brigham and Women's Hospital, United States

    6 publications · 392 citations

    6

    h-index

  2. MM
    Malcolm Maclure

    Harvard University, United States

    5 publications · 343 citations

    5

    h-index

  3. SB
    Stephen B. Soumerai

    Harvard University, United States

    4 publications · 329 citations

    4

    h-index

  4. CR
    Colin R. Dormuth

    University of British Columbia, Canada

    3 publications · 299 citations

    3

    h-index

  5. RJ
    Robert J. Glynn

    Brigham and Women's Hospital, United States

    3 publications · 295 citations

    3

    h-index

1–5 of 67

Venues

  1. PubMed

    Repository · 7 publications · 294 citations

    7

    h-index

  2. Health Policy

    4 publications · 134 citations

    4

    h-index

  3. New England Journal of Medicine

    NEJM · 2 publications · 209 citations

    2

    h-index

  4. Health Services Research

    HSR · 1 publications · 47 citations

    1

    h-index

  5. SSRN Electronic Journal

    Repository · 1 publications · 13 citations

    1

    h-index

1–5